The purpose of the company is to maximize value for the benefit of all stakeholders by holding and managing registered and unregistered intellectual property rights, as well as rights to potential regulatory and commercial milestone payments, under a cooperation agreement for the worldwide development and marketing of pharmaceutical products. The company does not engage in any activities other than the ownership and management of its assets. To avoid any misunderstanding, this also applies to the disposal of these assets. The company may, upon private or public offers, take out loans in any form. It may issue bonds, loans, and private or public debt securities of any kind. It may only issue participatory securities within the framework of private investments. It may lend funds to its subsidiaries and affiliated companies, including, among others, the proceeds from loans. It may generally, for its own benefit and for the benefit of other companies or persons, also grant guarantees and pledge, transfer, encumber, or provide security over its assets, in whole or in part, to secure its own liabilities and the liabilities of other companies. To avoid any misunderstanding, it should be noted that the company may not engage in regulated activities in the financial sector without obtaining the necessary authorization. The company may use all techniques and instruments related to its investments for efficient management. This includes techniques and instruments to protect the company from credit, currency, interest rate fluctuation, and other risks. The company may generally carry out all commercial, technical, and financial transactions that it deems necessary for the fulfillment and achievement of its purpose.
Outbound Leads by COHAGA